Newman-Tancredi A - Search Results

1

From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.

Sniecikowska J, Newman-Tancredi A, Kolaczkowski M. Sniecikowska J, et al. Curr Top Med Chem. 2019;19(26):2393-2420. doi: 10.2174/1568026619666190911122040. Curr Top Med Chem. 2019. PMID: 31544717 Review.

2

Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.

Cuisiat S, Bourdiol N, Lacharme V, Newman-Tancredi A, Colpaert F, Vacher B. Cuisiat S, et al. J Med Chem. 2007 Feb 22;50(4):865-76. doi: 10.1021/jm061180b. J Med Chem. 2007. PMID: 17300168

3

High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.

Maurel JL, Autin JM, Funes P, Newman-Tancredi A, Colpaert F, Vacher B. Maurel JL, et al. J Med Chem. 2007 Oct 4;50(20):5024-33. doi: 10.1021/jm070714l. Epub 2007 Sep 6. J Med Chem. 2007. PMID: 17803293

4

ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.

Kołaczkowski M, Mierzejewski P, Bieńkowski P, Wesołowska A, Newman-Tancredi A. Kołaczkowski M, et al. Br J Pharmacol. 2014 Feb;171(4):973-84. doi: 10.1111/bph.12509. Br J Pharmacol. 2014. PMID: 24199650 Free PMC article.

5

Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia.

Kołaczkowski M, Mierzejewski P, Bienkowski P, Wesołowska A, Newman-Tancredi A. Kołaczkowski M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):545-57. doi: 10.1007/s00210-014-0966-4. Epub 2014 Mar 6. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 24599316 Free PMC article.

6

Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT_1A receptor selective agonist, NLX-112 in mouse models of pain.

Sałat K, Kołaczkowski M, Furgała A, Rojek A, Śniecikowska J, Varney MA, Newman-Tancredi A. Sałat K, et al. Neuropharmacology. 2017 Oct;125:181-188. doi: 10.1016/j.neuropharm.2017.07.022. Epub 2017 Jul 24. Neuropharmacology. 2017. PMID: 28751195

7

Activity of Serotonin 5-HT_1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties.

Jastrzębska-Więsek M, Partyka A, Rychtyk J, Śniecikowska J, Kołaczkowski M, Wesołowska A, Varney MA, Newman-Tancredi A. Jastrzębska-Więsek M, et al. ACS Chem Neurosci. 2018 May 16;9(5):1040-1050. doi: 10.1021/acschemneuro.7b00443. Epub 2018 Jan 11. ACS Chem Neurosci. 2018. PMID: 29266914

8

Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT_1A receptor biased agonists.

Brys I, Halje P, Scheffer-Teixeira R, Varney M, Newman-Tancredi A, Petersson P. Brys I, et al. Exp Neurol. 2018 Apr;302:155-168. doi: 10.1016/j.expneurol.2018.01.010. Epub 2018 Jan 13. Exp Neurol. 2018. PMID: 29339052

9

In vivo biased agonism at 5-HT_1A receptors: characterisation by simultaneous PET/MR imaging.

Vidal B, Fieux S, Redouté J, Villien M, Bonnefoi F, Le Bars D, Newman-Tancredi A, Costes N, Zimmer L. Vidal B, et al. Neuropsychopharmacology. 2018 Oct;43(11):2310-2319. doi: 10.1038/s41386-018-0145-2. Epub 2018 Jul 6. Neuropsychopharmacology. 2018. PMID: 30030540 Free PMC article.

10

Serotonin 5-HT_1A Receptor Biased Agonists Induce Different Cerebral Metabolic Responses: A [¹⁸F]-Fluorodesoxyglucose Positron Emission Tomography Study in Conscious and Anesthetized Rats.

Levigoureux E, Vidal B, Fieux S, Bouillot C, Emery S, Newman-Tancredi A, Zimmer L. Levigoureux E, et al. ACS Chem Neurosci. 2019 Jul 17;10(7):3108-3119. doi: 10.1021/acschemneuro.8b00584. Epub 2019 Jan 7. ACS Chem Neurosci. 2019. PMID: 30576601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page